Research programme: viral infections therapeutics - Aqualis

Drug Profile

Research programme: viral infections therapeutics - Aqualis

Alternative Names: CP-4018; ganciclovir elaidate - Aqualis; ganciclovir elaidic acid - Aqualis

Latest Information Update: 17 Nov 2013

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Clavis Pharma
  • Developer Aqualis
  • Class Hypoxanthines; Small molecules
  • Mechanism of Action DNA-directed DNA polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • Available For Licensing Yes - Herpes simplex virus infections; Viral infections

Highest Development Phases

  • Discontinued Herpes simplex virus infections; Viral infections

Most Recent Events

  • 29 Aug 2013 Discontinued - Preclinical for Herpes simplex virus infections in Norway (unspecified route)
  • 29 Aug 2013 Discontinued - Preclinical for Viral infections in Norway (unspecified route)
  • 07 Feb 2011 Research programme: viral infections therapy - Clavis is available for licensing as of 07 Feb 2011. http://www.clavispharma.com
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top